OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction
Huajuan Jiang, Minmin Li, Kequn Du, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms
Jie Chen, Xiao‐Hong Wei, Qian Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 1919-1955
Open Access | Times Cited: 43

MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
Ka Iong Chan, Siyuan Zhang, Guodong Li, et al.
Aging and Disease (2024) Vol. 15, Iss. 2, pp. 640-640
Open Access | Times Cited: 17

Medicinal and mechanistic overview of artemisinin in the treatment of human diseases
Anna Maria Posadino, Roberta Giordo, Gianfranco Pintus, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114866-114866
Open Access | Times Cited: 31

Research progress of natural silk fibroin and the application for drug delivery in chemotherapies
Bin Yu, Yanli Li, Yuxian Lin, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 24

Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions
Yixuan Yu, Shuo Wang, Zhening Liu, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 17

The Application of Traditional Chinese Medicine-Derived Formulations in Cancer Immunotherapy: A Review
Yanyun Li, Changying Li, Jia Fan, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 23-34
Open Access

Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect
Yuhan Wang, Junsha An, Jianbo Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access

The Role of Ferulic Acid in Selected Malignant Neoplasms
Anna Markowska, Janina Markowska, Joanna Stanisławiak‐Rudowicz, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1018-1018
Open Access

Established UPLC-MS/MS procedure for multicomponent quantitative analysis of rat plasma: Pharmacokinetics of Taohong Siwu Decoction in normal and acute blood stasis models
Xinrui Wang, Jianzhong Lu, Guotong Li, et al.
Journal of Ethnopharmacology (2023) Vol. 305, pp. 116094-116094
Open Access | Times Cited: 10

Therapeutic potential of flavonoids used in traditional Chinese medicine – a comparative study of galangin, kaempferol, chrysin and fisetin
Arkadiusz Sokal, Klaudia Stocerz, Paweł Olczyk, et al.
Annales Academiae Medicae Silesiensis (2024) Vol. 78, pp. 49-60
Open Access | Times Cited: 3

Real-World Evidence of Traditional Chinese Medicine (TCM) Treatment on Cancer: A Literature-Based Review
Linjia Peng, Ke Zhang, Yujie Li, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 15

Traditional Chinese Medicine for Breast Cancer: A Review
Rui-Qi Feng, Dehui Li, Xukuo Liu, et al.
Breast Cancer Targets and Therapy (2023) Vol. Volume 15, pp. 747-759
Open Access | Times Cited: 7

Baicalein promotes KDM4E to induce BICD1 and inhibit triple‐negative breast cancer progression by blocking PAR1 signaling
Yun Dong, Gaojian He, Kun Chen, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1288-1302
Closed Access | Times Cited: 2

The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway
Hongkun Li, Jiawei Li, Yifan Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Integrated metabolomics and network pharmacology to reveal the therapeutic mechanism of Dingkun Pill on polycystic ovary syndrome
Ying‐li Cai, Feng Zhang, Xiuxiu Dou, et al.
Journal of Ethnopharmacology (2022) Vol. 295, pp. 115442-115442
Closed Access | Times Cited: 12

The cross-talk of autophagy and apoptosis in breast carcinoma: implications for novel therapies?
Kamil Seyrek, Fabian Wohlfromm, Johannes Espe, et al.
Biochemical Journal (2022) Vol. 479, Iss. 14, pp. 1581-1608
Closed Access | Times Cited: 12

Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells
Yunyun Zhang, Panpan Feng, Hongfei Wang, et al.
Chemico-Biological Interactions (2022) Vol. 365, pp. 110076-110076
Closed Access | Times Cited: 12

A comprehensive review of antitumor properties of Angelica species and their antitumor‐responsible constituents and the underlying molecular mechanisms involved in tumor inhibition
Zufa Sabeel, Youfeng Liang, Mingxuan Hao, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 5, pp. 2187-2211
Closed Access | Times Cited: 7

Biomimetic hybrid-cell membrane nanoparticles loaded with panaxytriol for breast cancer combinational therapy
Qian Xie, Bin Li, Jialong Fan, et al.
Materials & Design (2022) Vol. 223, pp. 111219-111219
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top